Edition:
United Kingdom

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

72.18USD
22 Jun 2018
Change (% chg)

$1.10 (+1.55%)
Prev Close
$71.08
Open
$71.59
Day's High
$72.61
Day's Low
$71.04
Volume
2,682,722
Avg. Vol
2,057,644
52-wk High
$84.00
52-wk Low
$60.15

Select another date:

Wed, May 2 2018

Photo

CVS beats on higher prescription drug sales, shares up 4 percent

CVS Health Corp posted a better-than-expected first-quarter profit on Wednesday, helped by higher sales of prescription drugs at its stores, sending its shares up 4.3 percent in trading before the bell. | Video

UPDATE 2-CVS beats on higher prescription drug sales, shares up 4 pct

May 2 CVS Health Corp posted a better-than-expected first-quarter profit on Wednesday, helped by higher sales of prescription drugs at its stores, sending its shares up 4.3 percent in trading before the bell.

BRIEF-CVS Health Reports Q1 GAAP EPS $0.98 From Continuing Operations

* CVS HEALTH REPORTS FIRST QUARTER RESULTS AND CONFIRMS 2018 FULL YEAR OUTLOOK

CVS Health profit rises 4.8 pct

May 2 CVS Health Corp, which is in the process of buying health insurer Aetna Inc, reported a 4.8 percent rise in quarterly profit on Wednesday, helped by higher sales of prescription drugs at its stores.

Health insurer Aetna beats estimates despite higher flu costs

U.S. health insurer Aetna Inc , which has agreed to be bought by CVS Health Inc , reported a better-than-expected first-quarter profit on Tuesday as an adjustment for low healthcare spending late last year offset a rise in flu-related costs.

UPDATE 2-Health insurer Aetna beats estimates despite higher flu costs

May 1 U.S. health insurer Aetna Inc, which has agreed to be bought by CVS Health Inc, reported a better-than-expected first-quarter profit on Tuesday as an adjustment for low healthcare spending late last year offset a rise in flu-related costs.

BRIEF-CVS Health Corp CEO's 2017 Compensation Was $12.25 Million

* CVS HEALTH CORP SAYS CEO LARRY J. MERLO'S 2017 TOTAL COMPENSATION WAS $12.25 MILLION – SEC FILING Source text (https://bit.ly/2FdHi0F) Further company coverage:

BRIEF-CVS Health Appoints Kevin Hourican As President Of CVS Pharmacy

* CVS HEALTH APPOINTS KEVIN HOURICAN AS PRESIDENT OF CVS PHARMACY Source text for Eikon: Further company coverage:

BRIEF-Cvs Health Expands Safe Drug Disposal At CVS Pharmacy Locations In West Virginia To Help Combat Opioid Abuse

* CVS HEALTH EXPANDS SAFE DRUG DISPOSAL AT CVS PHARMACY LOCATIONS IN WEST VIRGINIA TO HELP COMBAT OPIOID ABUSE Source text for Eikon: Further company coverage:

CVS Health appoints Marc-David Munk as CMO of MinuteClinic

CVS Health on Friday named Marc-David Munk as the new chief medical officer of MinuteClinic, the drugstore chain's retail medical clinic unit and as associate chief medical officer of the company.

Select another date: